lexisONE® Community
for State Bar of Wisconsin
Free Case Law Search Results
1. Astrazeneca Pharms. LP v. Teva Pharms. United States, Inc., 2008-1480, 2008-1481, UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT, September 25, 2009, Decided
OVERVIEW: In a patent infringement suit regarding the "atypical" antipsychotic drug quetiapine, summary judgment of no inequitable conduct was properly granted because, inter alia, the accused infringers offered no evidence or suggestion of deceptive intent, other than the fact that immaterial information was not provided.
Select a case name link to read the full display of the case — absolutely FREE!
If you are not a registered lexisONE® Community user, you will be asked to register.
Registration is free.
